share_log

Acrivon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(7.4%),Citadel Advisors Holdings LP(7.4%), etc.

Acrivon Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Citadel Advisors LLC(7.4%),Citadel Advisors Holdings LP(7.4%)等

SEC announcement ·  02/14 17:02
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息